Zero Risks. Zero Fees. Expand Your Portfolio. Partner with us. Pharma/Biotech Products.
Enterprise Bx is proud to have assembled a distinguished advisory board of directors who bring a wealth of knowledge and experience to our company. Our board members include:
Dr. Jeff Spitzner: Biotech Entrepreneur I Life Sciences Executive | Technology Commercialization | Investment Analysis | Molecular Cancer Research | Board Member, MIT Graduate
Enterprise Bx is fortunate to have Dr. Spitzner on its advisory board. A highly trained Entrepreneur's Biotech with several years of proven experience, Dr. Spitzer brings a unique blend of business acumen and technical expertise to the table.
Jeff Spitzner is a distinguished leader with over 20 years of experience as a founder and executive in the Life Sciences, Software, Investment, Bio-Technology, and Healthcare sectors. Jeff has significantly contributed over $35 million to the Columbus, OH community through his innovative leadership and strategic vision.
Jeff’s expertise spans a wide range of business skills, including product vision, technology commercialization, business development, investment analysis, strategic marketing, and technology direction. He is also adept in product management and development, investment fundraising and analysis, sales management, strategic partnering, executive leadership, team building, and consulting.
Jeff’s focus has always been on company formation and growth, bringing innovative products from concept to market. His academic credentials include a Ph.D. from Ohio State in molecular cancer research and a postdoctoral fellowship at MIT.
Throughout his career, Jeff has raised over $20 million in investments and secured $7 million in grants, creating over 90 new jobs. As CEO, he led a 300% sales growth in enterprise software, achieving over 100 enterprise customers and a $5 million exit for Visual Genomics. Currently, Jeff leads Amperand Consulting and serves as CEO of several Med tech companies, continually exploring new business opportunities.
Jeff Spitzner is our newest member of the board and is a key partner.